chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderate general body pain; Mild Headache; chills; Mild abdominal pain; received the first dose of bnt162b2 on left arm/ left arm pain; This is a spontaneous report from a contactable consumer reporting for herself. A 52-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EL3249, expiry date: not reported), via an unspecified route of administration, on 13Jan2021 07:00 PM at a single dose on left arm for COVID-19 immunization. The patient was not pregnant. The vaccine was administered at a hospital. The patient did not receive other vaccines in four weeks. The patient did not have covid prior to vaccination. Medical history included Diabetic type 2 and HBP (high blood pressure). She had no known allergies. Concomitant medications (other medications in two weeks) included losartan 100mg qd (once a day) and escitalopram 10mg qd (once a day). On 13Jan2021 10:00 PM, the patient experienced moderate general body pain, mild headache, chills, mild abdominal pain, left arm pain. The patient had undergone laboratory tests and procedures which included: covid test type = Blood test, covid test name = Serology, covid test date = 16Jul2020, covid test result=Negative; covid test date = 05Aug2020, covid test type = Nasal Swab, covid test name = Nasopharyngeal, covid test result = Negative. The patient did not receive any treatment for the reported adverse events. Outcome of the events was not recovered.
No adverse reaction was seen 15 min after vaccines were administered Child has a 2 week follow up appointment
pt felt dizzy right after shingrix #1. She said this happens sometimes which is why she was prepared and brought an electrolyte drink with her. She said she could "feel the liquid of the injection going into her arm and that it stung". After about 15 minutes and a cold pack and drinking her electrolytes she said she felt better and left the store on her own.
Narrative: 23-year-old male with a PMH of ADHD who reported to his primary care provider signs symptoms of headache, low grade fever of 100. IF, headache and rash on both arms a day after receiving J&J COVID-19 vaccine. The patient took 2 tablets of Tylenol and was advised by the provider to take diphenhydramine and continue support care. The patient declined getting tested for COVID 19 and agreed with the treatment plan. No other information available after that phone encounter
This case was reported by a physician via a sales representative and described the occurrence of not responding to therapy in a subject of unspecified age and gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On unspecified dates the subject received "a series" of ENGERIX B (unknown) and was found to have not responded to therapy. No additional details were reported. This event reportedly occurred with multiple subjects at this physician's office.
armpit sore or hurt; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (armpit sore or hurt) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (armpit sore or hurt). At the time of the report, AXILLARY PAIN (armpit sore or hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was unknown.
Left arm firm swelling and pain began the day after vaccination. Has progressed to left supraclavicular pain and swelling of that lymph node.
I developed significant pain; swelling under my right arm; I developed a significant visible lump-like swelling extending from my right arm pit to my right Pectoralis & Teres Minor muscles.; The swelling was about 3" in diameter, discolored with a rash-like pinkish tone; The swelling was about 3" in diameter, discolored with a rash-like pinkish tone; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 64 year-old adult female (Non pregnant) patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: not reported/Lot Number: 3013I8A), dose 3 via an unspecified route of administration, administered in Arm Right on 29Sep2021, at 15:30 as dose 3(BOOSTER), single for covid-19 immunisation. The patient previously received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: not reported/Lot Number: EP7534 & 3013I8A), via an unspecified route of administration, administered in Arm Right on 18Mar2021, at 09:00 AM (Age at the vaccination 64 years), as dose 2, single and first dose via an unspecified route of administration, administered in Arm Right on 26Feb2021, at 03:30 PM (Age at the vaccination 64 years), as dose 1, single for Covid-19 Immunization. Medical history included Grave's Disease, Celiac Disease, Raynaud's Disease from an unknown date and unknown if ongoing. Concomitant medications included methimazole (METHIMAZOLE) and olopatadine hydrochloride (PATADAY) taken for an unspecified indication, start and stop date were not reported. Patient did not receive other vaccine in four weeks. Patient did not received treatment as a result of AE. Patient not had covid prior to vaccination. On 30Sep2021, at 08:00 the patient developed significant pain, swelling under her right arm, developed a significant visible lump-like swelling extending from her right arm pit to her right Pectoralis & Teres Minor muscles, the swelling was about 3" in diameter, discolored with a rash-like pinkish tone. Timeframe between vaccination and starting of symptoms was 16 hrs 30 min. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal Swab) was negative on 04Oct2021. The outcome of the events was recovered.   Follow-Up (14Oct2021): Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a Registered Nurse referring to an adult patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On 25-JAN-2017, the patient received a pediatric dose of VAQTA Lot # M022924 and expiration date: 24-JAN-2018 (dose and route of administration were not reported) for prophylaxis, instead of an adult dose. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Pt reports no sxs until next day. She reports fatigue, severe h/a, paleness, cold sweats, rapid heart rate, nausea, fever 100.5. Area became extremely painful hot to-touch red swollen induration approx. 2 1/2 to 3 inches sharp stinging pains with itching.
Patient was given two doses of Hib vaccine. One was a single Hib vaccine. The other was Comvax (Hib/Hepatitis B). On f/u call 8/18/14, mother noted infant had a fever starting late in the day of 8/14/14 with a maximum temp of 102F. Mother called triage nurse. She was advised to give infant acetaminophen, cool compresses and tepid baths. The infant was in stable condition as of 8/17/14, afebrile, feeding well, voiding well, stools normal, alert per mother.
Approximately 16 days after VARIVAX given, baby developed pruritic maculopapular rash - first on arm, then face and over next 2 days spread to both arms & back. On 5/7/11 there were less than 20 lesions. No fever.
2 bloody stools; a 9 month old patient received third dose of VAXENUVANCE; This spontaneous report has been received from a nurse regarding to 9 month old female patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported.  On 06-APR-2023, the patient received the third dose of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) strength 0.5 ml administered with 3rd dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) strength 2.5/0.5 (unit unknown) for prophylaxis (dose, route, lot#, expiration date and indication were not reported) (inappropriate age at vaccine administration).  On 17-APR-2023, the patient experienced had 2 bloody stools. The outcome of the 2 bloody stools was unknown.  The causality assessment was not provided.  Upon internal review, 2 bloody stools was determined to be medically significant.
Extreme weakness; painful earache; chills, fever, muscle pain?? never been so sick in all my life.
Dizziness; Weakness; Chills; Fatigue; Swelling of the neck; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0153) via an unspecified route of administration in the left arm on 07Apr2021 at 09:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included fish oil (OMEGA 3) and cyanocobalamin (B 12), both taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced dizziness, weakness, chills, fatigue and swelling of the neck. On an unknown date in Apr2021, two weeks later, the patient experienced vertigo; fatigue and vertigo were present at the time of this report. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if any therapeutic measures were taken as a result of the events. On 19Apr2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. The clinical outcome of the events dizziness, weakness, chills and swelling of the neck were resolved with lasting effects on an unknown date in Apr2021, while fatigue and vertigo were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Starting 10/04/2022, I had a burning sensation in my throat for a couple of days. On the Thursday that week, I did a PCR test for COVID-19 (10/06/2022) and the following day (Friday) it came back positive. I called my doctor that day to see if I needed to start PAXLOVID, but due to not having many symptoms we decided not to start it. I had congestion and a slight headache. I was able to exercise and do normal activities that Saturday and Sunday. I wasn't negative until 10/10/2022. On 10/12/2022, I got the nasal congestion back for about 2 weeks with sinus drainage. On 10/17, I called her in regards to a sinus infection and was put on a Z-PAK for 10 days. When it did not work, I called my doctor who referred me to an ENT. On 12/06/2022, I ended up being treated for a sinus infection by an ENT and it just now cleared with usage of MEDROL dose pack and doxycycline.
The episode came on very quickly.  Felt like I was going to pass out.  Became very flushed, heart was racing and very shaky.  I work at a clinic, so my blood pressure was taken and it was 160/100, pulse was 120.  Had a bad head ache and continued to have waves of this for about an hour.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot number, expiry date, route and dose were not reported) and LIQUID PEDVAXHIB (Lot number, expiry date, route and dose were not reported). Certified Medical assistant reported that both vaccines were exposed to temperature of 26 F(Fahrenheit)for a total of 135 hours. No adverse effects reported. Follow-up received. Certified Medical assistant stated other 104 children received GARDASIL and other 18 children received LIQUID PEDVAXHIB. Follow up information has been received from the certified medical assistant regarding a 11 years old, male patient with no pertinent medical history reported. On 24-OCT-2012 the patient was vaccinated with a dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the right arm, dose not reported). Other suspect therapies included LIQUID PEDVAXHIB (lot number and expiration date not reported) (intramuscular on the right arm, dose not reported). Concomitant therapies included Hepatitis A vaccine (manufacturer unknown) administered on 24-OCT-2012 (intramuscular on the left arm, dose not reported). It was reported that the patient did not seek medical attention. This is one of the several reports from the same source. Additional information is not expected.
face is swollen; eyes are swollen, looks like someone punched her; felt cold; lower back hurts; sore arm; really tired; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts) and PAIN IN EXTREMITY (sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Past medical history not provided).   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts), PAIN IN EXTREMITY (sore arm) and FATIGUE (really tired). At the time of the report, SWELLING FACE (face is swollen), EYE SWELLING (eyes are swollen, looks like someone punched her), FEELING COLD (felt cold), BACK PAIN (lower back hurts), PAIN IN EXTREMITY (sore arm) and FATIGUE (really tired) outcome was unknown.            Concomitant medications taken by the patient were not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Pt c/o difficulty breathing, anxiety, felt like having heart palpitations.  Lungs clear, VS WNL.  Pt felt better after water and rest.  Patient stable and released from vaccination site.
Patient fainted approximately 3 minutes following vaccination. She regained consciousness within 30 seconds and was given water. Patient completely recovered within 5 minutes and no further adverse effects occured.
Few min p/receiving TD/MMR pt collapsed sz activity noted for few seconds; Skin diaphoretic; Pulse regular & strong; Pupils equal; Responded to speaking & able to state name p/sz; Dx probable sz activity 2 degree to hypoglycemia rxn (BS-50;
Macular blanchy rash, start 3pm 05/11/06, resolved on 5/15/2006 no sequelae.
Swollen lymph node in left armpit; Vaginal bleeding/spotting; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old female patient (not pregnant) received BNT162b2 (BNT162B2; Solution for injection), on 19Jun2022 at 09:15 as dose 3 (booster), single (Lot number: Fp7135) at the age of 31 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: FLUOXETINE; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE]. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: En6203, Location of injection: Arm Left), administration date: 25Feb2021, when the patient was 30-year-old, for Covid-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: El9269, Location of injection: Arm Left), administration date: 04Feb2021, when the patient was 30-year-old, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 20Jun2022, outcome "recovered", described as "Swollen lymph node in left armpit"; VAGINAL HAEMORRHAGE (non-serious) with onset 20Jun2022, outcome "recovered", described as "Vaginal bleeding/spotting". Therapeutic measures were not taken as a result of lymphadenopathy, vaginal haemorrhage.  Additional information: Swollen lymph node in left armpit for 5 days, vaginal bleeding/spotting for 5 days. I have never had spotting before in my life. Even when pregnant. This is what concerns me the most. If covid prior vaccination: No. If covid tested post vaccination: No. No Known allergies.  No follow-up attempts are possible. No further information is expected.
Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023.; No adverse event; Patient had expired vaccine that was administered on March 15,2023 there was between 75 and 125 people that was vaccinated.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had expired vaccine that was administered on March 15,2023 there was between 75 and 125 people that was vaccinated.), PRODUCT STORAGE ERROR (Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023.) and NO ADVERSE EVENT (No adverse event) in a 25-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 060B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had expired vaccine that was administered on March 15,2023 there was between 75 and 125 people that was vaccinated.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had expired vaccine that was administered on March 15,2023 there was between 75 and 125 people that was vaccinated.), PRODUCT STORAGE ERROR (Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient had expired vaccine that was administered on March 15,2023 there was between 75 and 125 people that was vaccinated.) and PRODUCT STORAGE ERROR (Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023.).    Concomitant medication use information was not provided by reporter.  There was between 75 and 125 people vaccinated and then on 3/3/23. HCP states that expired Moderna COVID-19 monovalent vaccine was administered to approximately 75-125 people on 15MAR2023.   There was potentially a second lot number that was expired and was administered to patients on 3MAR2023, but HCP did not have any details on this event at this time.  Dose administered after 30-day use by date or after manufacturer date of expiry  Individual vials or intact cartons was unknown  Vial size was reported as 10 dose vial  Date the vial was initially stored in the refrigerator was reported as 14 March 2023  The vial did not undergo any temperature excursions.  Treatment Medication use information was not provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-716065 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716065:case
Received Pneumovax 23 and meningoccocal conjugate (Menactra) vaccinations on Tuesday 7/24/2012 and developed a rash at the site of injection and associated with Fever (102F).
Urticaria - BENADRYL 3 days after H1N1 vaccination given. No other symptoms. Rash continues 12-8-09
I experienced daily palpitations several times a day for 6-7 weeks following the vaccine.  The skipped heartbeats were so severe that they woke me from sleep.
Ever since receiving the first dose of the vaccine on August 28, 2021, I have been experiencing a long-term side effect. Initially, I had the normal reported side effects such as a sore arm, headache and generalized weakness. The same day of the initial shot, I began experiencing vagina bleeding within 8 hours. The blood was bright red and very heavy. I have been filling pads within one hour and this is very abnormal even with my prior condition of pcos. I have never in my life experienced such bleeding even on menstrual cycle. This has been going on since the first dose and has worsened after my second dose. I am very concerned for my health.
Approximately 4 years post vax, this pt was dxed with varicella described as "red spots all over his body, quantity unk, with itching."
intense pain at injection site.  Large bump and redness.  Pain up and down arm.  General body pain and general feeling of illness
Infection in Lungs; SICKNESS; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (Infection in Lungs) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic obstructive pulmonary disease, Bronchiectasis and Lung disease (Lung condition). Concomitant products included ALBUTEROL [SALBUTAMOL], SODIUM CHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), ALPRAZOLAM (XANAX), FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY), ROFLUMILAST, TIZANIDINE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), GLYCERYL TRINITRATE (NITROGLYCERINE), CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]), MAGNESIUM, TRIAMCINOLONE, COLECALCIFEROL (D3) and OMEPRAZOLE for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (Infection in Lungs) (seriousness criterion medically significant) and ILLNESS (SICKNESS). At the time of the report, PNEUMONIA (Infection in Lungs) and ILLNESS (SICKNESS) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Clicking in left ear my Dr told me it was Tinnitus on 3/9/2021